生命科學工具與試劑：全球市場

Life Science Tools and Reagents: Global Markets

出版日期: 2024年06月28日 | 出版商:

BCC Research | 英文 132 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

包括COVID-19診斷在內的全球生命科學工具和試劑市場規模預計將從2023年的594億美元成長到2024年的532億美元，預測期內複合年成長率為4.6%，到2024年將達到66.5億美元預計到年終將達到10億美元。

生命科學工具和試劑產業預計將從 2024 年的 513 億美元增加到 2029 年的 664 億美元，複合年成長率為 5.3%。此外，COVID-19 診斷測試產業預計將從 2024 年的 19 億美元增至 2029 年的 1.073 億美元，複合年成長率為 43.5%。

該報告調查了全球生命科學工具和試劑市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測，以及按各個細分市場和地區進行的細主要企業。

按細分市場細分
市場分析：按類型
COVID-19 診斷測試市場
生命科學工具和試劑市場
市場區隔：按應用
基因組學
蛋白質體學
細胞生物學
幹細胞
影像工具和技術
動物模型
表觀遺傳學工具和試劑
生命科學工具和試劑
其他
地域分佈
市場區隔：按地區
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

主要企業分析
PCR技術與試劑
微孔盤/ELISA 裝置
抗體
酵素連結免疫吸附試驗
生命科學套件和檢測
COVID-19 診斷
戰略分析
產品介紹
合作與合約
M&A
其他策略發展

第7章生命科學工具與試劑市場的永續性：ESG 視角

ESG：簡介
環境
社會問題
管治
生命科學工具和試劑產業的 ESG 績效分析
包裹
ESG風險評估
ESG相關機會與風險
BCC的結語

第8章附錄

調查方法
簡稱
來源
公司簡介
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

The global market for life science tools and reagents is expected to grow from $51.3 billion in 2024 to reach $66.4 billion by 2029, at a CAGR of 5.3% during the forecast period of 2024-2029.

The global market for COVID-19 diagnostics tests is expected to decline from $1.9 billion in 2024 to reach $107.3 million by 2029, at a negative CAGR of 43.5% during the forecast period of 2024-2029.

Report Scope

This report provides an analysis of the market for life sciences tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape and market dynamics such as drivers, restraints and opportunities. It sizes of the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science instruments include hybridization systems, PCR, Western blotting instruments, and ELISA instruments. The regions whose markets are analyzed are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Markets are also analyzed by application.

Report Includes

85 data tables and 44 additional tables
An analysis of the global markets for life science tools and reagents, including COVID-19 diagnostics products
Analyses of the global market trends, with market revenue data (sales figures) from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
An estimate of the market size and revenue forecast for the market for life science tools and diagnostics, and a corresponding market share analysis based on product type, application and region
Highlights of the current and future market potential of life science tools and diagnostics, along with an analysis of the competitive landscape, regulatory scenario and technological advances
Facts and figures pertaining to the market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables
An assessment of current products and identification of new potential markets for novel products and assay development
A discussion on how scientific trends, government policies and the economy in general affect this market, as well as how the life science tools and diagnostics industry differs from the pharmaceutical and drug discovery industry
A discussion of sustainability trends in the market, with emphasis on consumer attitudes, an analysis of companies' ESG scores, the future of ESG, case studies, and the ESG practices of leading companies
An analysis of the key patent grants and recently published patents
Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activity and the outlook for venture funding
Profiles of the leading market players, including Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Roche and Qiagen

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Product Development in Life Science
PESTLE Analysis
Political
Economic
Social
Technological
Environmental
Legal
Environmental
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Increasing Investments in R&D
Diagnostic Pathways
Prevalence of Chronic Diseases
Broadening Range of Applications
Market Restraints
End of COVID-19 pandemic
Cybersecurity
Lack of Reproducibility of Antibodies
Market Challenges
End Users and Regulatory Compliance
Market Opportunities
Infectious Diseases on the Rise
New Technologies

Chapter 4 Emerging Technologies and Developments

AI and Machine Learning
Internet of Things (IoT)
Automation of Data Collection
Tracking of Equipment
Remote Analysis
Interconnectivity
Predictive Maintenance
Robots in Life Science Labs
3D/4D Cell Culturing
Reduced Use of Harmful Chemicals

Chapter 5 Market Segmentation Analysis

Segmental Breakdown
Market Analysis by Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
Market Breakdown by Application
Genomics
Proteomics
Cell Biology
Stem Cells
Imaging Tools and Techniques
Animal Models
Epigenetics Tools and Reagents
Metabolomics
Other Applications
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Analysis of Leading Companies
PCR Technologies and Reagents
Microplate Readers/ELISA Instruments
Antibodies
ELISA Tests
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Analysis
Product Introductions
Collaborations and Agreements
Mergers and Acquisitions
Other Strategic Developments

Chapter 7 Sustainability in the Life Sciences Tools and Reagents Market: An ESG Perspective

Introduction to ESG
Environment
Social Issues
Governance
ESG Performance Analysis in the Life Science Tools and Reagents Industry
Packaging
ESG Risk Ratings
ESG-related Opportunities and Risks
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
Abbreviations
Sources
Company Profiles
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029
Table 1 : Differences Between Basic and Applied Research
Table 2 : Pandemics of the 21st Century
Table 3 : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029
Table 4 : Global Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 5 : Global Market for COVID-19 Molecular Tests, by Region, Through 2029
Table 6 : North American Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7 : European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 8 : Asia-Pacific Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 9 : Global Market for COVID-19 Antigen Tests, by Region, Through 2029
Table 10 : North American Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 11 : European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 12 : Asia-Pacific Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 13 : Global Market for COVID-19 Serological Tests, by Region, Through 2029
Table 14 : North American Market for COVID-19 Serological Tests, by Country, Through 2029
Table 15 : European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 16 : Asia-Pacific Market for COVID-19 Serological Tests, by Country, Through 2029
Table 17 : Global Market for Life Science Tools and Reagents, by Type, Through 2029
Table 18 : Global Market for Life Science Tools and Reagents, by Region, Through 2029
Table 19 : North American Market for Life Science Tools and Reagents, by Country, Through 2029
Table 20 : European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 21 : Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029
Table 22 : Global Market for Life Science Instruments, by Region, Through 2029
Table 23 : North American Market for Life Science Instruments, by Country, Through 2029
Table 24 : European Market for Life Science Instruments, by Country, Through 2029
Table 25 : Asia-Pacific Market for Life Science Instruments, by Country, Through 2029
Table 26 : Global Market for Life Science Reagents and Kits, by Region, Through 2029
Table 27 : North American Market for Life Science Reagents and Kits, by Country, Through 2029
Table 28 : European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 29 : Asia-Pacific Market for Life Science Reagents and Kits, by Country, Through 2029
Table 30 : Global Market for Life Science Tools and Reagents, by Application, Through 2029
Table 31 : Global Market for Genomics, by Region, Through 2029
Table 32 : North American Market for Genomics, by Country, Through 2029
Table 33 : European Market for Genomics, by Country, Through 2029
Table 34 : Asia-Pacific Market for Genomics, by Country, Through 2029
Table 35 : Global Market for Proteomics, by Region, Through 2029
Table 36 : North American Market for Proteomics, by Country, Through 2029
Table 37 : European Market for Proteomics, by Country, Through 2029
Table 38 : Asia-Pacific Market for Proteomics, by Country, Through 2029
Table 39 : Global Market for Cell Biology, Antibodies and Recombinant Proteins, by Region, Through 2029
Table 40 : North American Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 41 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 42 : Asia-Pacific Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 43 : Global Market for Stem Cell Research, by Region, Through 2029
Table 44 : North American Market for Stem Cell Research, by Country, Through 2029
Table 45 : European Market for Stem Cell Research, by Country, Through 2029
Table 46 : Asia-Pacific Market for Stem Cell Research, by Country, Through 2029
Table 47 : Global Market for Imaging Tools and Techniques, by Region, Through 2029
Table 48 : North American Market for Imaging Tools and Techniques, by Country, Through 2029
Table 49 : European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 50 : Asia-Pacific Market for Imaging Tools and Techniques, by Country, Through 2029
Table 51 : Global Market for Animal Models, by Region, Through 2029
Table 52 : North American Market for Animal Models, by Country, Through 2029
Table 53 : European Market for Animal Models, by Country, Through 2029
Table 54 : Asia-Pacific Market for Animal Models, by Country, Through 2029
Table 55 : Global Market for Epigenetic Tools and Reagents, by Region, Through 2029
Table 56 : North American Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 57 : European Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 58 : Asia-Pacific Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 59 : Global Market for Metabolomics, by Region, Through 2029
Table 60 : North American Market for Metabolomics, by Country, Through 2029
Table 61 : European Market for Metabolomics, by Country, Through 2029
Table 62 : Asia-Pacific Market for Metabolomics, by Country, Through 2029
Table 63 : Global Market for Other Applications of Life Science Tools and Reagents, by Region, Through 2029
Table 64 : North American Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 65 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 66 : Asia-Pacific Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 67 : Global Market for Life Science Tools and Reagents, by Region, Through 2029
Table 68 : North American Market for Life Science Tools and Reagents, by Country, Through 2029
Table 69 : North American Market for Life Science Tools and Reagents, by Type, Through 2029
Table 70 : North American Market for COVID-19 Diagnostics, by Country, Through 2029
Table 71 : European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 72 : European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 73 : European Market for COVID-19 Diagnostics, by Country, Through 2029
Table 74 : Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029
Table 75 : Asia-Pacific Market for Life Science Instruments and Reagents, by Type, Through 2029
Table 76 : Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2029
Table 77 : RoW Market for Life Science Instruments and Reagents, by Type, Through 2029
Table 78 : Ranking of Life Science Tool and Reagent Companies, by Revenue, 2023
Table 79 : Leading Providers of PCR Technologies, by Revenue, 2023
Table 80 : Leading Providers of ELISA Instruments/Microplate Readers, by Revenue, 2023
Table 81 : Leading Suppliers of Antibodies, by Revenue, 2023
Table 82 : Leading Providers of ELISA Tests, by Revenue, 2023
Table 83 : Leading Providers of Kits and Assay Tests, by Revenue, 2023
Table 84 : Leading Providers of COVID-19 Diagnostics Tools, by Revenue, 2023
Table 85 : Recent New Life Science Tools and Reagents, 2022-2024
Table 86 : Collaborations in the Life Science Tools and Reagents Market, 2021-2024
Table 87 : Recent Acquisitions in the Market for Life Science Tools and Reagents, 2021-2024
Table 88 : Other Recent Developments in the Life Science Tools and Reagents Market, 2021-2024
Table 89 : ESG Ratings of the Leading Providers of Life Science Tools and Reagents
Table 90 : List of Abbreviations Used in the Report
Table 91 : Report Sources
Table 92 : BD: Company Snapshot
Table 93 : BD: Financial Performance, FY 2022 and 2023
Table 94 : BD: Product Portfolio
Table 95 : BD: News/Key Developments, 2021-2024
Table 96 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 97 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 98 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 99 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 100 : Danaher Corp.: Company Snapshot
Table 101 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 102 : Danaher Corp.: Product Portfolio
Table 103 : Danaher Corp.: News/Key Developments, 2021-2023
Table 104 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 105 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 106 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 107 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2023
Table 108 : Merck KGaA: Company Snapshot
Table 109 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 110 : Merck KGaA: Product Portfolio
Table 111 : Merck KGaA: News/Key Developments, 2021 and 2022
Table 112 : Promega Corp.: Company Snapshot
Table 113 : Promega Corp.: Product Portfolio
Table 114 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 115 : Qiagen: Company Snapshot
Table 116 : Qiagen: Financial Performance, FY 2022 and 2023
Table 117 : Qiagen: Product Portfolio
Table 118 : Revvity: Company Snapshot
Table 119 : Revvity: Financial Performance, FY 2022 and 2023
Table 120 : Revvity: Product Portfolio
Table 121 : Revvity: News/Key Developments, 2023 and 2024
Table 122 : Takara Bio Inc.: Company Snapshot
Table 123 : Takara Bio Inc.: Financial Performance, FY 2022 and 2023
Table 124 : Taraka Bio Inc.: Product Portfolio
Table 125 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 126 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 127 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 128 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

Summary Figure : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, 2021-2029
Figure 1 : Market Dynamics of Life Sciences Tools and Reagents Market
Figure 2 : R&D Spending, by Academic Institutions, 2021-2022
Figure 3 : Venture Capital Funding in Life Science, 2021-2022
Figure 4 : New Diagnostic Techniques
Figure 5 : Percentage of Deaths from Non-Communicable Diseases, by Income Level, 2023
Figure 6 : Reasons for Increase in Pandemics
Figure 7 : Global Market Shares of COVID-19 Diagnostics, by Type, 2023
Figure 8 : Types of ELISA
Figure 9 : Global Market for Life Science Tools and Reagents, by Application, 2024 and 2029
Figure 10 : Global Market for Life Science Tools and Reagents, by Region, 2021-2029
Figure 11 : U.S. Spendings on Life Sciences R&D, 2001 vs. 2019
Figure 12 : U.S. Market for Life Science Tools and Diagnostics, 2021-2029
Figure 13 : Canadian Market for Life Science Tools and Diagnostics, 2021-2029
Figure 14 : Mexican Market for Life Science Tools and Diagnostics, 2021-2029
Figure 15 : U.K. Market for Life Science Tools and Diagnostics, 2021-2029
Figure 16 : German Market for Life Science Tools and Diagnostics, 2021-2029
Figure 17 : French Market for Life Science Tools and Diagnostics, 2021-2029
Figure 18 : Rest of the European Market for Life Science Tools and Diagnostics, 2021-2029
Figure 19 : Chinese Population Aging Over 60, 2019 and 2040
Figure 20 : Chinese Market for Life Science Tools and Diagnostics, 2021-2029
Figure 21 : Share of Aging Population in Japan, 2019 and 2040
Figure 22 : Japanese Market for Life Science Tools and Diagnostics, 2021-2029
Figure 23 : Indian Market for Life Science Tools and Diagnostics, 2021-2029
Figure 24 : Rest of Asia-Pacific Market for Life Science Tools and Diagnostics, 2021-2029
Figure 25 : Factors Impacting the Environment
Figure 26 : BD: Revenue Share, by Business Unit, FY 2023
Figure 27 : BD: Revenue Share, by Country/Region, FY 2023
Figure 28 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 29 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 31 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 32 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 33 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 35 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 36 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 37 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 38 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 39 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 40 : Takara Bio Inc.: Revenue Share, by Business Unit, FY 2023
Figure 41 : Takara Bio Inc.: Revenue Share, by Country/Region, FY 2023
Figure 42 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023